CorMedix CRMD Enterprise value

Enterprise value at other companies

PfizerPFE

$222.4B+9.2%

Merck & Co.MRK

$367.21B+59.3%

Merit Medical SystemsMMSI

$4.43B-33.3%

IAR

Integra LifeSciencesIART

$3.15B+20.7%

ICU MedicalICUI

$4.67B+8.0%

TFX

TeleflexTFX

$8.28B+17.5%

FAQ

What is CorMedix's enterprise value?

CorMedix (CRMD) reported enterprise value of $774.78M in Q4 2025.

How has CorMedix's enterprise value changed year-over-year?

CorMedix's enterprise value increased by 71.7% year-over-year, from $451.25M to $774.78M.

What is the long-term trend for CorMedix's enterprise value?

Over 5 years (2020 to 2025), CorMedix's enterprise value has grown at a 26.2% compound annual growth rate (CAGR), from $241.92M to $774.78M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.